Prof. Dr. Gerold Schuler



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Anti-PD-1 Therapy in SUFU mutant Patients with Gorlin-Goltz Syndrome (2018) Moreira A, Kirchberger MC, Toussaint F, Erdmann M, Schuler G, Heinzerling L Conference contribution BRAF and MEK inhibitors change human immune cell phenotype and function; possible consequences for combination therapy (2018) Hoyer S, Eberlein V, Babalija L, Gerer K, Walter L, Schuler G, Schaft N, et al. Conference contribution Comparative analysis of human dendritic cell subpopulations in steady state and inflammation (2018) Heger L, Heidkamp GF, Lehmann C, Söder S, Hartmann A, Alexiou C, Schuler G, et al. Conference contribution Tumor-suppressing Plasma extracellular Vesicles (pEV) from Melanoma Patients are secreted by Liver Cells and PBMC (2018) Baur A, Lee JH, Eberhardt M, Blume K, Schuler G, Vera González J Conference contribution The Generation of CAR-transfected NKT Cells for the Immunotherapy of Melanoma (2018) Simon B, Wiesinger M, Marz J, Wistuba-Hamprecht K, Weide B, Schuler-Thurner B, Schuler G, et al. Conference contribution Neuromuscular Side Effects of Immune Checkpoint Inhibitors (2018) Moreira A, Loquai C, Knauss S, Gutzmer R, Dimitriou F, Meier F, Heppt M, et al. Conference contribution Ex vivo expanded NK Cells from Melanoma Patients receive their Migration in a 3D Model and lyse autologous Melanoma Cells (2018) Rossner S, Czerwinski T, Mark C, Gross S, Karg M, Bosch JJ, Schuler-Thurner B, et al. Conference contribution Extracellular Vesicles in the Plasma of Melanoma Patients under-press beta Catenin in Tumor Cells by using miRNA-34a (2018) Baur A, Lee JH, Dindorf J, Eberhardt M, Lai X, Ostalecki C, Koliha N, et al. Conference contribution Eosinophilic Fasciitis by Treatment with Checkpoint Inhibitors in metastatic Melanoma (2018) Toussaint F, Erdmann M, Moreira A, Kirchberger MC, Schuler G, Heinzerling L Conference contribution Expression of Senescence Markers - Is Predictive for Immune Therapy with Checkpoint Inhibitors? (2018) Moreira A, Gross S, Kirchberger MC, Erdmann M, Schuler G, Heinzerling L Conference contribution